Simplex Trading’s Asterias Biotherapeutics Inc. Series A AST Stock Holding History

Simplex Trading’s Portfolio AST Stock Details AST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-1,842	Closed	-$1K	–	8452
2018 Q4	$1K	Buy	+1,842	New	+$1.91K	﹤0.01%	6878
2018 Q2	–	Sell	-25,038	Closed	-$38.4K	–	8372
2018 Q1	$36K	Buy	25,038 +3,142	+14%	+$6.56K	﹤0.01%	2776
2017 Q4	$49K	Buy	21,896 +14,391	+192%	+$36.4K	﹤0.01%	2480
2017 Q3	$25K	Buy	7,505 +1,190	+19%	+$4K	﹤0.01%	2969
2017 Q2	$22K	Sell	6,315 -10,956	-63%	-$36.1K	﹤0.01%	3240
2017 Q1	$58K	Buy	+17,271	New	+$67.2K	﹤0.01%	2237

Simplex Trading's AST Position: Q1 2019 in Review

Simplex Trading sold out of Asterias Biotherapeutics Inc. Series A (AST) in Q1 2019, closing a stake of 1,842 shares — an estimated $1K sold.

Simplex Trading first reported a position in AST in Q1 2017 and held it in 6 quarters. The position peaked at $58K in Q1 2017. 0 funds tracked by Wall St. Rank hold AST as of Q1 2019.

Simplex Trading reported no remaining Asterias Biotherapeutics Inc. Series A position as of Q1 2019 after selling out during the quarter.
Simplex Trading sold 1,842 Asterias Biotherapeutics Inc. Series A shares in Q1 2019, an estimated $1K.
Simplex Trading first reported a position in Asterias Biotherapeutics Inc. Series A in Q1 2017 and held it in 6 quarters.
Simplex Trading's Asterias Biotherapeutics Inc. Series A position peaked at $58K in Q1 2017.
0 funds tracked by Wall St. Rank held Asterias Biotherapeutics Inc. Series A as of Q1 2019.

Based on Simplex Trading's 13F filing for Q1 2019, filed 18 Apr 2019.